GHK-Cu
Copper tripeptide-1
GHK-Cu is a naturally occurring copper-binding peptide found in human plasma, used for years as a cosmetic skincare ingredient. Injectable use is a separate question, and FDA has not yet decided whether pharmacies may compound it.
Key facts
- Commonly discussed for: skin quality, wound healing and hair.
- Evidence (C): Human data are small topical studies, such as a randomized trial in which 13 laser-resurfacing patients completed follow-up and blinded raters found no difference in redness or wrinkles; most wound-healing data are from animals. FDA notes limited human data for injectable use.
- FDA status: Awaiting FDA review. Injectable GHK-Cu was removed from FDA's Category 2 list in April 2026 but is not on the 503A Bulks List; the PCAC is scheduled to review it at a meeting before the end of February 2027.
- Legitimate access: No clear legal route yet.
- Last reviewed: October 1, 2026.
Read the deep dives
Common questions
Is GHK-Cu FDA approved?
No. GHK-Cu is not an FDA-approved drug. It is widely used as a cosmetic skincare ingredient, which is a different category from a drug.
Can pharmacies compound injectable GHK-Cu?
Not on a settled basis yet. FDA removed injectable GHK-Cu from its Category 2 safety-concern list in April 2026, but it is not on the 503A Bulks List. The Pharmacy Compounding Advisory Committee is scheduled to review it before the end of February 2027.
Is GHK-Cu skincare legal?
Yes. Topical cosmetic products with copper peptides are sold legally as cosmetics, as long as they are not marketed to treat or cure a disease.
Sources
- Pickart et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int, 2015
- Miller et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg, 2006
- FDA: Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2 list)
- FDA: Meeting of the Pharmacy Compounding Advisory Committee (upcoming 2027 meeting)